Abstract:Six years ago, Radbruch and colleagues discussed in Nature Reviews Immunology (Organization of immunological memory by bone marrow stroma. Nat. Rev. Immunol. 10, 193-200 (2010)) 1 how distinct stromal cell subsets in the bone marrow can support the lifelong persistence of plasma cells and memory T cells. These authors proposed that the bone marrow might serve as a depot for resting noncirculating memory T cells. Furthermore, they discussed how memory T cells might be maintained in the bone marrow by survival … Show more
“…A single study in humans did use DNA staining and found that an average of <0.1% of memory‐phenotype CD8 T cells were in S‐G 2 /M in the blood of donors with no systemic diseases . The interpretation at that time was that blood‐derived memory CD8 T cells are resting . Our interpretation is instead that the cells in S‐G 2 /M could have been newly activated cells responding to an environmental antigen.…”
Section: Discussionmentioning
confidence: 85%
“…36 The interpretation at that time was that blood-derived memory CD8 T cells are resting. 36,38,39 Our interpretation is instead that the cells in S-G 2 /M could have been newly activated cells responding to an environmental antigen. We suggest that the widespread use of our technical approach might prevent incomplete data analysis and/or biased interpretations.…”
Although clonal expansion is a hallmark of adaptive immunity, the location(s) where antigen‐responding T cells enter cell cycle and complete it have been poorly explored. This lack of knowledge stems partially from the limited experimental approaches available. By using Ki67 plus DNA staining and a novel strategy for flow cytometry analysis, we distinguished antigen‐specific CD8 T cells in G0, in G1 and in S‐G2/M phases of cell cycle after intramuscular vaccination of BALB/c mice with antigen‐expressing viral vectors. Antigen‐specific cells in S‐G2/M were present at early times after vaccination in lymph nodes (LNs), spleen and, surprisingly, also in the blood, which is an unexpected site for cycling of normal non‐leukaemic cells. Most proliferating cells had high scatter profile and were undetected by current criteria of analysis, which under‐estimated up to 6 times antigen‐specific cell frequency in LNs. Our discovery of cycling antigen‐specific CD8 T cells in the blood opens promising translational perspectives.
“…A single study in humans did use DNA staining and found that an average of <0.1% of memory‐phenotype CD8 T cells were in S‐G 2 /M in the blood of donors with no systemic diseases . The interpretation at that time was that blood‐derived memory CD8 T cells are resting . Our interpretation is instead that the cells in S‐G 2 /M could have been newly activated cells responding to an environmental antigen.…”
Section: Discussionmentioning
confidence: 85%
“…36 The interpretation at that time was that blood-derived memory CD8 T cells are resting. 36,38,39 Our interpretation is instead that the cells in S-G 2 /M could have been newly activated cells responding to an environmental antigen. We suggest that the widespread use of our technical approach might prevent incomplete data analysis and/or biased interpretations.…”
Although clonal expansion is a hallmark of adaptive immunity, the location(s) where antigen‐responding T cells enter cell cycle and complete it have been poorly explored. This lack of knowledge stems partially from the limited experimental approaches available. By using Ki67 plus DNA staining and a novel strategy for flow cytometry analysis, we distinguished antigen‐specific CD8 T cells in G0, in G1 and in S‐G2/M phases of cell cycle after intramuscular vaccination of BALB/c mice with antigen‐expressing viral vectors. Antigen‐specific cells in S‐G2/M were present at early times after vaccination in lymph nodes (LNs), spleen and, surprisingly, also in the blood, which is an unexpected site for cycling of normal non‐leukaemic cells. Most proliferating cells had high scatter profile and were undetected by current criteria of analysis, which under‐estimated up to 6 times antigen‐specific cell frequency in LNs. Our discovery of cycling antigen‐specific CD8 T cells in the blood opens promising translational perspectives.
“…Both cytokines are both important for CD8 + T-cell maintenance, but with a different underlying mechanism: IL-15 is a potent proliferative agent for CD8 + memory T cells [39,40], whereas IL-7 rather induces their survival [41,42]. Whether CD8 + memory T-cell maintenance in the BM depends on proliferation or survival is a matter that is currently heavily debated [3,4,6,[43][44][45][46][47]. This discussion will greatly benefit from conclusive evidence that IL-7 and/or IL-15 produced by CXCL12 high stromal cells support CD8 + T-cell maintenance in the BM, which requires conditional deletion of these cytokines from BM stromal cells.…”
The BM serves as a blood‐forming organ, but also supports the maintenance and immune surveillance function of many T cells. Yet, in contrast to other organs, little is known about the molecular mechanisms that drive T‐cell migration to and localization inside the BM. As BM accumulates many CXCR3‐expressing memory CD8+ T cells, we tested the involvement of this chemokine receptor, but found that CXCR3 is not required for BM entry. In contrast, we could demonstrate that CXCR4, which is highly expressed on both naive and memory CD8+ T cells in BM, is critically important for homing of all CD8+ T‐cell subsets to the BM in mice. Upon entry into the BM parenchyma, both naïve and memory CD8+ T cells locate close to sinusoidal vessels. Intravital imaging experiments revealed that CD8 T cells are surprisingly immobile and we found that they interact with ICAM‐1+VCAM‐1+BP‐1+ perivascular stromal cells. These cells are the major source of CXCL12, but also express key survival factors and maintenance cytokines IL‐7 and IL‐15. We therefore conclude that CXCR4 is not only crucial for entry of CD8+ T cells into the BM, but also controls their subsequent localization toward BM niches that support their survival.
“…In contrast to the anticipated role of T RM in other tissues—to provide local protection at sites of pathogen entry—such bone-marrow memory T cells (T BM ) are thought to contribute to systemic memory [24]. Interestingly, in many respects the phenotype of T BM resembles that of T RM cells, with relatively high expression of CD69, and low expression of S1P 1 and Klf2 [25,26].…”
Section: Part I: Thinking Kinetically—how Long Is a Memory?mentioning
Long-term T cell-mediated protection depends upon the formation of a pool of memory cells to protect against future pathogen challenge. In this review we argue that looking at T cell memory from a dynamic viewpoint can help in understanding how memory populations are maintained following pathogen exposure or vaccination. For example, a dynamic view resolves the apparent paradox between the relatively short lifespans of individual memory cells and very long-lived immunological memory by focussing on the persistence of clonal populations, rather than individual cells. Clonal survival is achieved by balancing proliferation, death and differentiation rates within and between identifiable phenotypic pools; such pools correspond broadly to sequential stages in the linear differentiation pathway. Each pool has its own characteristic kinetics, but only when considered as a population; single cells exhibit considerable heterogeneity. In humans, we tend to concentrate on circulating cells, but memory T cells in non-lymphoid tissues and bone marrow are increasingly recognised as critical for immune defence; their kinetics, however, remain largely unexplored. Considering vaccination from this viewpoint shifts the focus from the size of the primary response to the survival of the clone and enables identification of critical system pinch-points and opportunities to improve vaccine efficacy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.